Safety and efficacy of US-guided HIFU treatment for HCC patients

Not Applicable

Recruiting

• Conditions: hepatocellular carcinoma (HCC)

• Registration Number: JPRN-UMIN000016099
• Lead Sponsor: Yokohama City University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1) HCC is adjust intestine 2)T-Bil 3.0mg<, <PT 50% 3)bleeding tendency (<Plt 50000/mm3) 4)patients with pregnancy 5)patients with their prognosis <3 months 6)patients the doctor judged as a non-indication from the medical ormental status

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
safety

Secondary Outcome Measures

Name	Time	Method
efficacy